September 1-5, 2024Rome, Italy

The EFMC is the main organisation for the European Medicinal Chemistry and Chemical Biology community, with 30 member societies and about 9.000 members. Its biennial EFMC-ISMC is a key symposium in the field of medicinal chemistry and drug discovery and it traditionally attracts around 1.000 participants both from industry and academia. The most recent EFMC-ISMC meeting took place in France (Nice, 2022).

The 2024 programme will include:

Three parallel sessions with different themes:

  1. Chemical Biology
  2. Drug Discovery Projects
  3. Technologies

In addition, the programme contains five open sessionsFirst Time Disclosures (I & II)Late Breaking News/Recent DevelopmentsHighlights in Medicinal Chemistry as well as a special session on Early Career Women in Medicinal Chemistry & Chemical Biology. For these sessions, the talks will be selected from the submitted abstracts.

For most of the below topics, two slots in the programme will be available for an oral communication selected out of the submitted abstracts.

Deadlines

Calendar of Abstract Submissions

  • Deadline for Oral Communication submission and free Poster submission: March 21, 2024, 24:00 CET
  • Announcement of the accepted oral communications: mid May 2024
  • After March 21 and until June 20, 2024, abstracts for Posters can still be submitted, but with a handling fee of 50,00€

Registration Fees

  • Early-bird registration deadline: March 21, 2024
    Payment of the Early-bird fee is required by April 5, 2024 in order to remain applicable.
  • Standard registration deadline: July 2, 2024
  • Late registration deadline: September 1, 2024
Organised by:
  • Division of Medicinal Chemistry of the Italian Chemical Society (Divisione di Chimica Farmaceutica - Società Chimica Italiana, DCF-SCI) (Italy)
  • European Federation for Medicinal Chemistry and Chemical Biology (EFMC)

Rules for Organizers of International Symposia on Medicinal Chemistry (EFMC-ISMC)

The rules for the organization of an Interantional Symposium on Medicinal Chemistry are explained in point D. of the by-laws

By-Laws